PFM Health Sciences as of June 30, 2022
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 79 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | 4.2 | $109M | 615k | 177.51 | |
| Cytokinetics Com New (CYTK) | 3.7 | $97M | 2.5M | 39.29 | |
| Eli Lilly & Co. (LLY) | 3.7 | $97M | 299k | 324.23 | |
| Centene Corporation (CNC) | 3.6 | $94M | 1.1M | 84.61 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.4 | $89M | 572k | 156.01 | |
| Merck & Co (MRK) | 3.4 | $89M | 972k | 91.17 | |
| Horizon Therapeutics Pub L SHS | 3.3 | $87M | 1.1M | 79.76 | |
| Arcus Biosciences Incorporated (RCUS) | 3.2 | $85M | 3.3M | 25.34 | |
| Humana (HUM) | 3.0 | $78M | 166k | 468.07 | |
| Pfizer (PFE) | 2.7 | $70M | 1.3M | 52.43 | |
| BioMarin Pharmaceutical (BMRN) | 2.7 | $70M | 839k | 82.87 | |
| Avantor (AVTR) | 2.5 | $65M | 2.1M | 31.10 | |
| UnitedHealth (UNH) | 2.2 | $57M | 112k | 513.63 | |
| Irhythm Technologies (IRTC) | 2.0 | $53M | 494k | 108.03 | |
| Axsome Therapeutics (AXSM) | 2.0 | $52M | 1.4M | 38.30 | |
| Seagen | 1.9 | $50M | 282k | 176.94 | |
| Iqvia Holdings (IQV) | 1.8 | $48M | 222k | 216.99 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.8 | $48M | 3.8M | 12.59 | |
| Biomarin Pharmaceutical Note 0.599% 8/0 (Principal) | 1.7 | $46M | 46M | 0.99 | |
| Danaher Corporation (DHR) | 1.7 | $45M | 176k | 253.52 | |
| Uniqure Nv SHS (QURE) | 1.6 | $42M | 2.2M | 18.64 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 1.6 | $41M | 48M | 0.85 | |
| Molina Healthcare (MOH) | 1.5 | $40M | 144k | 279.61 | |
| Veeva Sys Cl A Com (VEEV) | 1.5 | $40M | 202k | 198.04 | |
| ICU Medical, Incorporated (ICUI) | 1.5 | $40M | 242k | 164.39 | |
| Argenx Se Sponsored Adr (ARGX) | 1.5 | $40M | 105k | 378.88 | |
| Waters Corporation (WAT) | 1.5 | $39M | 118k | 330.98 | |
| Astrazeneca Sponsored Adr (AZN) | 1.5 | $38M | 577k | 66.07 | |
| Abbvie (ABBV) | 1.4 | $38M | 246k | 153.16 | |
| Cigna Corp (CI) | 1.4 | $37M | 141k | 263.52 | |
| McKesson Corporation (MCK) | 1.3 | $35M | 106k | 326.21 | |
| Icon SHS (ICLR) | 1.3 | $34M | 158k | 216.70 | |
| Biogen Call Call Option | 1.3 | $34M | 167k | 203.94 | |
| Thermo Fisher Scientific (TMO) | 1.3 | $34M | 62k | 543.28 | |
| Cardinal Health (CAH) | 1.3 | $33M | 640k | 52.27 | |
| Erasca (ERAS) | 1.2 | $33M | 5.9M | 5.57 | |
| Caribou Biosciences (CRBU) | 1.2 | $33M | 6.0M | 5.43 | |
| Becton, Dickinson and (BDX) | 1.2 | $32M | 131k | 246.53 | |
| Edwards Lifesciences (EW) | 1.2 | $32M | 338k | 95.09 | |
| Universal Hlth Svcs CL B (UHS) | 1.2 | $32M | 317k | 100.71 | |
| Nevro (NVRO) | 1.1 | $29M | 659k | 43.83 | |
| Tenet Healthcare Corp Com New (THC) | 1.1 | $29M | 545k | 52.56 | |
| Catalent | 0.9 | $23M | 218k | 107.29 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $23M | 2.2M | 10.58 | |
| Penumbra (PEN) | 0.9 | $23M | 183k | 124.52 | |
| Myriad Genetics (MYGN) | 0.8 | $21M | 1.2M | 18.17 | |
| Baxter International (BAX) | 0.8 | $21M | 324k | 64.23 | |
| Anthem (ELV) | 0.8 | $21M | 43k | 482.59 | |
| Generation Bio (GBIO) | 0.7 | $18M | 2.8M | 6.56 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $17M | 1.2M | 14.25 | |
| Karuna Therapeutics Ord | 0.6 | $17M | 130k | 126.51 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.6 | $16M | 9.1M | 1.70 | |
| Verve Therapeutics (VERV) | 0.5 | $13M | 845k | 15.28 | |
| Karuna Therapeutics Call Call Option | 0.5 | $13M | 100k | 126.51 | |
| Jounce Therapeutics | 0.5 | $12M | 3.9M | 3.03 | |
| Procept Biorobotics Corp (PRCT) | 0.4 | $12M | 358k | 32.69 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $11M | 581k | 19.24 | |
| Iteos Therapeutics (ITOS) | 0.4 | $11M | 538k | 20.60 | |
| Oak Street Health | 0.4 | $10M | 619k | 16.44 | |
| Io Biotech (IOBT) | 0.4 | $10M | 2.2M | 4.67 | |
| Prothena Corp SHS (PRTA) | 0.4 | $9.4M | 345k | 27.15 | |
| Iveric Bio | 0.3 | $8.7M | 906k | 9.62 | |
| Intellia Therapeutics (NTLA) | 0.3 | $8.5M | 163k | 51.76 | |
| Praxis Precision Medicines I | 0.3 | $8.1M | 3.3M | 2.45 | |
| Dynavax Technologies Corp Note 2.500% 5/1 (Principal) | 0.3 | $7.5M | 5.0M | 1.50 | |
| Editas Medicine (EDIT) | 0.3 | $7.4M | 630k | 11.83 | |
| Werewolf Therapeutics (HOWL) | 0.3 | $7.1M | 1.7M | 4.09 | |
| Seagen Call Call Option | 0.3 | $7.1M | 40k | 176.95 | |
| Sight Sciences (SGHT) | 0.3 | $7.0M | 776k | 8.99 | |
| Sophia Genetics Sa Ordinary Shares (SOPH) | 0.2 | $6.4M | 1.8M | 3.62 | |
| Sana Biotechnology (SANA) | 0.2 | $6.1M | 953k | 6.43 | |
| Biocryst Pharmaceuticals Call Call Option | 0.2 | $5.8M | 550k | 10.58 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $5.4M | 385k | 14.09 | |
| Aerie Pharmaceuticals | 0.2 | $5.2M | 700k | 7.50 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $4.6M | 464k | 9.90 | |
| Jiya Acquisition Corp Com Cl A | 0.2 | $4.6M | 464k | 9.88 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $4.2M | 393k | 10.82 | |
| Essa Pharma Com New (EPIX) | 0.1 | $3.0M | 962k | 3.15 | |
| Pardes Biosciences | 0.1 | $2.5M | 801k | 3.07 |
